Literature DB >> 8216355

Different biotransformation of morphine in isolated liver cells from guinea pig and rat.

T A Aasmundstad1, A Ripel, E Bodd, A Bjørneboe, J Mørland.   

Abstract

The biotransformation of morphine was characterized in freshly isolated parenchymal and non-parenchymal liver cells from rats and guinea pigs in suspension culture to establish an in vitro model for morphine metabolism. Liver cells were prepared by a collagenase perfusion technique, and separated by differential centrifugation. Morphine metabolism was investigated at different concentrations (1, 5, 100 and 200 microM). Samples were taken repeatedly during 2-4 hr of incubation, and subsequently analysed on a HPLC system employing both UV and electrochemical detection. In suspensions of hepatocytes from both animal species morphine-3-glucuronide (M3G) was the major metabolite of morphine, and was formed at comparable rates at all concentrations examined. Guinea pig hepatocytes in addition produced considerable quantities of morphine-6-glucuronide (M6G), whereas this metabolite was detected only intracellularly in minor quantities in rat hepatocytes. The ratio between the two morphine glucuronides (M3G/M6G) in suspensions of guinea pig hepatocytes was approximately 4:1. N-Demethylation of morphine was more pronounced per mg cell protein in rat hepatocytes compared to guinea pig cells. Metabolic activity towards morphine was not detected in non-parenchymal cells of the two species. The morphine glucuronidation pattern found in guinea pig hepatocytes resembles to a greater extent than that found in rat hepatocytes the pattern found in in vivo studies of humans. It was concluded that isolated guinea pig parenchymal cells appeared to be a promising in vitro system for studies of morphine glucuronidation, and to observe metabolism in general.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216355     DOI: 10.1016/0006-2952(93)90659-k

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment.

Authors:  Liliana Bachs; Gudrun Høiseth; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2006-10-05       Impact factor: 2.953

Review 2.  Developing a vaccine against multiple psychoactive targets: a case study of heroin.

Authors:  G Neilm Stowe; Joel E Schlosburg; Leandro F Vendruscolo; Scott Edwards; Kaushik K Misra; Gery Schulteis; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

3.  Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose.

Authors:  T A Aasmundstad; B Q Xu; I Johansson; A Ripel; A Bjørneboe; A S Christophersen; E Bodd; J Mørland
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

4.  Evidence of active transport involvement in morphine transport via MDCKII and MDCK-PGP cell lines.

Authors:  S O Mashayekhi; M R Sattari; P A Routledge
Journal:  Res Pharm Sci       Date:  2010-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.